LY294002 10mg 10mg | Purity Not Available
Adooq Bioscience
LY294002 is a PI3k inhibitor (cell IC50 about 10 ??M) and a casein kinase II inhibitor.
More Information Supplier PageLY294002 is a PI3k inhibitor (cell IC50 about 10 ??M) and a casein kinase II inhibitor.
More Information Supplier PageLY2784544 is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
More Information Supplier PageLY2784544 is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
More Information Supplier PageLY2784544 is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
More Information Supplier PageLY2784544 is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
More Information Supplier PageLY2784544 is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
More Information Supplier PageLY2228820 is a novel and potent p38MAPK inhibitor with potent antiinflammatory activity.
More Information Supplier PageLY294002 is a PI3k inhibitor (cell IC50 about 10 ??M) and a casein kinase II inhibitor.
More Information Supplier PageLY294002 is a PI3k inhibitor (cell IC50 about 10 ??M) and a casein kinase II inhibitor.
More Information Supplier PageLY335979 (Zosuquidar trihydrochloride) is a potent highly selective P-gp inhibitor.
More Information Supplier Page